<abstract xmlns="http://www.w3.org/1999/xhtml">The use of biological therapies may have positive impact on chronic renal disease associated with rheumatoid arthritis.The study evaluates retrospectively renal function in 57 patients with rheumatoid arthritis treated with different types of biological therapy, comparative with 62 RA patients treated conservatively with DMARDs.Patients treated with biological therapies presented a lower mean value for serum creatinine measured both at baseline and after 6 months of treatment, statistically significant compared with the subgroup treated with DMARDs (0.69 ± 0.17 mg/dL vs. 1.18 ± 1.01 mg/dL, p = 0.003). Results for estimated filtration rate were significantly increased in biologically treated cohort (100.36 ± 16.76 mL/min/1.73 m2 vs. 63.49 ± 21.60 mL/min/1.73 m2, p &lt; 0.00001). Rituximab presented a better estimated filtration rate compared with other biological tharapies (eGFR 97.037 mL/min/1.73 m2 vs. 90.933 mL/min/1.73 m2).The positive effect of potent biological anti-inflammatory therapies sustains the need of further exploring the risk of reduced kidney function in immune-mediated diseases, including rheumatoid arthritis.</abstract>

The use of biological therapies may have positive impact on chronic renal disease associated with rheumatoid arthritis.The study evaluates retrospectively renal function in 57 patients with rheumatoid arthritis treated with different types of biological therapy, comparative with 62 RA patients treated conservatively with DMARDs.Patients treated with biological therapies presented a lower mean value for serum creatinine measured both at baseline and after 6 months of treatment, statistically significant compared with the subgroup treated with DMARDs (0.69 ± 0.17 mg/dL vs. 1.18 ± 1.01 mg/dL, p = 0.003). Results for estimated filtration rate were significantly increased in biologically treated cohort (100.36 ± 16.76 mL/min/1.73 m2 vs. 63.49 ± 21.60 mL/min/1.73 m2, p < 0.00001). Rituximab presented a better estimated filtration rate compared with other biological tharapies (eGFR 97.037 mL/min/1.73 m2 vs. 90.933 mL/min/1.73 m2).The positive effect of potent biological anti-inflammatory therapies sustains the need of further exploring the risk of reduced kidney function in immune-mediated diseases, including rheumatoid arthritis.

Renal disease in patients with rheumatoid arthritis treated with biological therapy

Department II Preclinical Disciplines, Faculty of Medicine, University “Ovidius” of Constanta

Department III Clinical Disciplines Health, Faculty of Medicine, University “Ovidius” of Constanta

ARS Medica Tomitana

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

The use of biological therapies may have positive impact on chronic renal disease associated with rheumatoid arthritis.The study evaluates retrospectively...

Renal disease in patients with rheumatoid arthritis treated with biological therapy

Publicado en línea: 11 jun 2016

Páginas: 50 - 55

DOI: https://doi.org/10.1515/arsm-2016-0009

Palabras clave
rheumatoid arthritis, biological therapy, estimated glomerular filtration rate (eGFR)

© 2016 Hanzu-Pazara Loredana et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Renal disease in patients with rheumatoid arthritis treated with biological therapy

Publicado en línea: 11 jun 2016

Páginas: 50 - 55

DOI: https://doi.org/10.1515/arsm-2016-0009

Palabras claverheumatoid arthritis, biological therapy, estimated glomerular filtration rate (eGFR)

© 2016 Hanzu-Pazara Loredana et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Palabras clave
rheumatoid arthritis, biological therapy, estimated glomerular filtration rate (eGFR)